Rolston PaulOperations field notes

Videos / Film

Film: Advertising treatment abroad to UK patients: the ASA's 2026 report

6 minutes. The field note, shown rather than read.

Chapters

  1. 0:00 The UK's advertising rules
  2. 0:16 The first promise a patient hears
  3. 0:39 How I would run ad compliance for UK audiences
  4. 0:54 The rules it applies are the CAP Code
  5. 1:15 What the ASA found
  6. 1:37 Two problems stood out
  7. 1:55 The ASA then acted
  8. 2:12 Compliance rose
  9. 2:34 It matters for the business too
  10. 2:49 Rules a clinic often misses
  11. 3:29 The second is about age
  12. 3:59 The pre-run check
  13. 4:25 A monthly sample
  14. 4:44 Where the trade-off sits
  15. 5:04 There is also a cost in speed
  16. 5:19 How India competes on evidence

The field note

Transcript

0:00 The UK's advertising rules

A clinic outside the UK that runs ads aimed at people in the UK is held to the UK's advertising rules, and in March 2026 the UK regulator showed it is watching clinics abroad closely.

0:16 The first promise a patient hears

This matters because an ad is the first promise a patient hears, and an ad that rushes or shames a patient starts the care relationship on pressure instead of evidence. A countdown timer on surgery tells the patient that speed matters more than the decision. An ad that needs a countdown is selling the clock, not the care.

0:39 How I would run ad compliance for UK audiences

I would give every ad aimed at UK audiences an owner, a written check before it runs and a record of who approved it. The owner sits in marketing. The record shows the ad, the date, the audience setting and the approver.

0:54 The rules it applies are the CAP Code

The regulator is the Advertising Standards Authority, or ASA. The rules it applies are the CAP Code, written by the Committee of Advertising Practice. On 12 March 2026 the ASA published an enforcement report on cosmetic surgery abroad. It is not legal advice.

1:15 What the ASA found

The ASA's report covers paid ads on Meta's social media platforms from clinics based abroad. It ran from December 2024 to December 2025. The ASA said it captured more than 4,000 paid ads for cosmetic surgery across two phases of monitoring.

1:37 Two problems stood out

Two problems stood out in the report. The first was "mommy makeover" packages that, in the ASA's words, exploited body insecurities in new mothers. The second was time-limited offers that pressured people into making rushed decisions about surgery.

1:55 The ASA then acted

The ASA then acted. It contacted advertisers whose ads breached the CAP Code and told them to remove or amend the problem claims. Where advertisers did not respond, it escalated the issue through Meta.

2:12 Compliance rose

The ASA's report says compliance rose from 61.4% to 86.9% in the first phase and from 41.7% to 70.6% in the second. The ASA says it tracks these ads with an AI-based monitoring system, so this is not a one-off sweep.

2:34 It matters for the business too

It matters for the business too. An ad that is removed after a regulator's letter wastes the spend. Worse, a UK patient who later reads about the report may wonder what else the clinic cut corners on.

2:49 Rules a clinic often misses

Two other ASA and CAP pages are worth reading with the report. CAP's guidance on botulinum toxin, the anti-wrinkle injection, says it is a prescription-only medicine and cannot be advertised to the public, under CAP rule 12.12 and regulations from the MHRA, the UK medicines regulator. The same page says it can be mentioned on a clinic's own website only as a possible outcome of a consultation or in a price list, and only in a purely informational way. It says it cannot be mentioned in paid advertising or on social media.

3:29 The second is about age

The second is about age. The ASA's regulatory statement on cosmetic interventions says that rules preventing these ads from being directed at under-18s took effect from 25 May 2022. The same CAP guidance adds that ads for non-surgical cosmetic treatments cannot appear in non-broadcast media where under-18s make up 25% or more of the audience.

3:59 The pre-run check

The pre-run check needs only a few questions: Does the ad set a deadline, a countdown or a "today only" price for a surgical procedure? If so, remove it. Does it play on how a person feels about their body after pregnancy, ageing or weight change? If so, rewrite it. Does it mention a prescription-only medicine, directly or by a nickname? If so, remove it.

4:25 A monthly sample

Is the audience set to exclude under-18s? Can every claim in the ad be shown to be true with a document the clinic holds? I would also run a monthly sample. A second person pulls ten live ads at random and runs the same check. Any failure goes back to the owner with a date to fix it.

4:44 Where the trade-off sits

These controls cost reach. A time-limited offer may well lift clicks in the short term. I would accept fewer clicks. A patient who books because a timer was running has not yet decided, and a patient who has not decided is the one most likely to cancel or complain.

5:04 There is also a cost in speed

There is also a cost in speed. A written check and an approver add a day to each campaign. I would keep that day. It is cheaper than a regulator's letter, and it gives the clinic a record to show if a question ever comes.

5:19 How India competes on evidence

For India, the stakes are larger than one clinic. An Indian clinic that meets the UK standard in its ads shows overseas patients the same discipline they should expect from its care, and that is how India competes on evidence rather than on pressure. Clinics in India that adopt this before they are asked will have an easier time with every overseas regulator, not only the UK's.